J. Rahmahani, R. Z. F. A. M. Wudhu, S. Suwarno, Martia Rani Tacharina
{"title":"传染性支气管炎本地和麻州毒株的免疫原性","authors":"J. Rahmahani, R. Z. F. A. M. Wudhu, S. Suwarno, Martia Rani Tacharina","doi":"10.20473/jmv.vol5.iss1.2022.98-102","DOIUrl":null,"url":null,"abstract":"This study aimed to compare the immunogenicity between the whole virus and protein S of both local strain I-147 and Massachusetts strain of Infectious bronchitis virus with indirect ELISA. 24 healthy mice are divided into four groups with six mice in each group that are: P1) a group of mice that are vaccinated with S protein (spike glycoprotein) of local strain Infectious Bronchitis virus; P2) a group of mice that are vaccinated with S protein (spike glycoprotein) of Massachusetts strain Infectious Bronchitis virus; P3) a group of mice that are vaccinated with the whole virus of local strain Infectious Bronchitis virus; P4) a group of mice that are vaccinated with the whole virus of Massachusetts strain Infectious Bronchitis virus. The results of this research are Optical Density (OD) values of each treatment, then to be analyzed using One Way ANOVA and followed by Duncan Multiple Range Test 5% and T-test. The results show that there are differences in immunogenicity between the whole virus and S protein in both the local strain and Massachusetts strain of Infectious bronchitis virus. The OD value of the whole virus in the two strains has a significant difference from the OD value of the protein S antigen in both strains, both in the serum taken at week 2 and week 4 post-vaccination.","PeriodicalId":17972,"journal":{"name":"Jurnal Medik Veteriner","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunogenicity of Local and Massachusetts Strains Infectious Bronchitis Virus\",\"authors\":\"J. Rahmahani, R. Z. F. A. M. Wudhu, S. Suwarno, Martia Rani Tacharina\",\"doi\":\"10.20473/jmv.vol5.iss1.2022.98-102\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This study aimed to compare the immunogenicity between the whole virus and protein S of both local strain I-147 and Massachusetts strain of Infectious bronchitis virus with indirect ELISA. 24 healthy mice are divided into four groups with six mice in each group that are: P1) a group of mice that are vaccinated with S protein (spike glycoprotein) of local strain Infectious Bronchitis virus; P2) a group of mice that are vaccinated with S protein (spike glycoprotein) of Massachusetts strain Infectious Bronchitis virus; P3) a group of mice that are vaccinated with the whole virus of local strain Infectious Bronchitis virus; P4) a group of mice that are vaccinated with the whole virus of Massachusetts strain Infectious Bronchitis virus. The results of this research are Optical Density (OD) values of each treatment, then to be analyzed using One Way ANOVA and followed by Duncan Multiple Range Test 5% and T-test. The results show that there are differences in immunogenicity between the whole virus and S protein in both the local strain and Massachusetts strain of Infectious bronchitis virus. The OD value of the whole virus in the two strains has a significant difference from the OD value of the protein S antigen in both strains, both in the serum taken at week 2 and week 4 post-vaccination.\",\"PeriodicalId\":17972,\"journal\":{\"name\":\"Jurnal Medik Veteriner\",\"volume\":\"19 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal Medik Veteriner\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20473/jmv.vol5.iss1.2022.98-102\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Medik Veteriner","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20473/jmv.vol5.iss1.2022.98-102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
本研究旨在用间接ELISA法比较传染性支气管炎本地株I-147和马萨诸塞州株全病毒和蛋白S的免疫原性。将24只健康小鼠分为4组,每组6只,分别为:P1)接种本地株传染性支气管炎病毒S蛋白(刺突糖蛋白)的小鼠组;P2)接种马萨诸塞州株传染性支气管炎病毒S蛋白(刺突糖蛋白)的小鼠组;P3)接种本地株传染性支气管炎病毒全病毒的小鼠组;P4)一组小鼠接种了马萨诸塞州传染性支气管炎病毒株的全病毒。本研究结果为各处理的光密度(OD)值,采用单因素方差分析(One - Way ANOVA)进行分析,并采用Duncan多元极差检验5%和t检验。结果表明,传染性支气管炎本地株和麻州株的全病毒和S蛋白的免疫原性存在差异。接种后第2周和第4周血清中两株全病毒OD值与两株蛋白S抗原OD值存在显著差异。
Immunogenicity of Local and Massachusetts Strains Infectious Bronchitis Virus
This study aimed to compare the immunogenicity between the whole virus and protein S of both local strain I-147 and Massachusetts strain of Infectious bronchitis virus with indirect ELISA. 24 healthy mice are divided into four groups with six mice in each group that are: P1) a group of mice that are vaccinated with S protein (spike glycoprotein) of local strain Infectious Bronchitis virus; P2) a group of mice that are vaccinated with S protein (spike glycoprotein) of Massachusetts strain Infectious Bronchitis virus; P3) a group of mice that are vaccinated with the whole virus of local strain Infectious Bronchitis virus; P4) a group of mice that are vaccinated with the whole virus of Massachusetts strain Infectious Bronchitis virus. The results of this research are Optical Density (OD) values of each treatment, then to be analyzed using One Way ANOVA and followed by Duncan Multiple Range Test 5% and T-test. The results show that there are differences in immunogenicity between the whole virus and S protein in both the local strain and Massachusetts strain of Infectious bronchitis virus. The OD value of the whole virus in the two strains has a significant difference from the OD value of the protein S antigen in both strains, both in the serum taken at week 2 and week 4 post-vaccination.